Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jasper Stevens

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Pharmacology Research & Perspectives|February 9, 2018
Fosfomycin as a potential therapy for the treatment of systemic infections: a population pharmacokinetic model to simulate multiple dosing regimensNatalia V Ortiz Zacarías, Anneke C Dijkmans, Jacobus Burggraaf, et al.
Foot & Ankle International|October 23, 2016
Gait Analysis of Foot Compensation After Arthrodesis of the First Metatarsophalangeal JointJasper Stevens, Kenneth Meijer, Wouter Bijnens, et al.
Antibiotics (Basel, Switzerland)|November 1, 2017
Fosfomycin: Pharmacological, Clinical and Future PerspectivesAnneke Corinne Dijkmans, Natalia Veneranda Ortiz Zacarías, Jacobus Burggraaf, et al.
British Journal of Clinical Pharmacology|November 19, 2016
The use of a battery of pain models to detect analgesic properties of compounds: a two-part four-way crossover studyPieter Okkerse, Guido van Amerongen, Marieke L de Kam, et al.
Clinical Pharmacology and Therapeutics|September 7, 2022
Studying Telmisartan Plasma Exposure, Kidney Distribution, Receptor Occupancy, and Response in Patients With Type 2 Diabetes Using [<sup>11</sup> C]TelmisartanSjoukje van der Hoek, Douwe J Mulder, Antoon T M Willemsen, et al.
Therapeutic Drug Monitoring|April 28, 2016
Population Pharmacokinetics of Prednisolone in Relation to Clinical Outcome in Children With Nephrotic SyndromeNynke Teeninga, Zheng Guan, Jasper Stevens, et al.
Diabetes, Obesity & Metabolism|August 31, 2019
Exposure and response analysis of aleglitazar on cardiovascular risk markers and safety outcomes: An analysis of the AleCardio trialJeroen V Koomen, Hiddo J L Heerspink, Ilse C Schrieks, et al.
Clinical Kidney Journal|October 17, 2025
Comparison of radioactive and non-radioactive iothalamate and hippuran to assess kidney functionAbdulfataah A A Mohamed, Ron T Gansevoort, Nico C van de Merbel, et al.
Clinical Pharmacology in Drug Development|June 12, 2019
Effect of Food on the Pharmacokinetics of 2 Formulations of DRL-17822, a Novel Selective Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy MalesAnnelieke C Kruithof, Rajinder Kumar, Jasper Stevens, et al.
Journal of Personalized Medicine|May 27, 2023
Exposure-Response Analysis of the Sodium-Glucose Cotransporter-2 Inhibitors Dapagliflozin and Empagliflozin on Kidney Hemodynamics in Patients with Type 2 DiabetesSjoukje van der Hoek, Jeroen V Koomen, Erik J M van Bommel, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Pharmacology Research & Perspectives|February 9, 2018
Fosfomycin as a potential therapy for the treatment of systemic infections: a population pharmacokinetic model to simulate multiple dosing regimensNatalia V Ortiz Zacarías, Anneke C Dijkmans, Jacobus Burggraaf, et al.
Foot & Ankle International|October 23, 2016
Gait Analysis of Foot Compensation After Arthrodesis of the First Metatarsophalangeal JointJasper Stevens, Kenneth Meijer, Wouter Bijnens, et al.
Antibiotics (Basel, Switzerland)|November 1, 2017
Fosfomycin: Pharmacological, Clinical and Future PerspectivesAnneke Corinne Dijkmans, Natalia Veneranda Ortiz Zacarías, Jacobus Burggraaf, et al.
British Journal of Clinical Pharmacology|November 19, 2016
The use of a battery of pain models to detect analgesic properties of compounds: a two-part four-way crossover studyPieter Okkerse, Guido van Amerongen, Marieke L de Kam, et al.
Clinical Pharmacology and Therapeutics|September 7, 2022
Studying Telmisartan Plasma Exposure, Kidney Distribution, Receptor Occupancy, and Response in Patients With Type 2 Diabetes Using [<sup>11</sup> C]TelmisartanSjoukje van der Hoek, Douwe J Mulder, Antoon T M Willemsen, et al.
Therapeutic Drug Monitoring|April 28, 2016
Population Pharmacokinetics of Prednisolone in Relation to Clinical Outcome in Children With Nephrotic SyndromeNynke Teeninga, Zheng Guan, Jasper Stevens, et al.
Diabetes, Obesity & Metabolism|August 31, 2019
Exposure and response analysis of aleglitazar on cardiovascular risk markers and safety outcomes: An analysis of the AleCardio trialJeroen V Koomen, Hiddo J L Heerspink, Ilse C Schrieks, et al.
Clinical Kidney Journal|October 17, 2025
Comparison of radioactive and non-radioactive iothalamate and hippuran to assess kidney functionAbdulfataah A A Mohamed, Ron T Gansevoort, Nico C van de Merbel, et al.
Clinical Pharmacology in Drug Development|June 12, 2019
Effect of Food on the Pharmacokinetics of 2 Formulations of DRL-17822, a Novel Selective Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy MalesAnnelieke C Kruithof, Rajinder Kumar, Jasper Stevens, et al.
Journal of Personalized Medicine|May 27, 2023
Exposure-Response Analysis of the Sodium-Glucose Cotransporter-2 Inhibitors Dapagliflozin and Empagliflozin on Kidney Hemodynamics in Patients with Type 2 DiabetesSjoukje van der Hoek, Jeroen V Koomen, Erik J M van Bommel, et al.
Pageof 8